Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2C-B prodrug
- Development stage
- Preclinical
- Lead developer
- Terran Biosciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
2C-B prodrug is a small molecule therapeutic candidate being developed by Terran Biosciences for the treatment of various neuropsychiatric disorders. The compound is designed as a prodrug of 2C-B (4-bromo-2,5-dimethoxyphenethylamine), a psychedelic phenethylamine that primarily acts as a partial agonist at the serotonin 5-HT2A receptor. By utilizing a prodrug approach, Terran aims to optimize the pharmacokinetic profile, potentially improving the oral bioavailability and therapeutic window of 2C-B. The program is part of Terran's broader pipeline of psychedelic-based therapies targeting mental health conditions.
- Other names
- 2C-B prodrug
02
Targets
HTR2C (5-hydroxytryptamine 2C receptor)HTR2A (Serotonin receptor 5-HT2A)HTR1B (5-Hydroxytryptamine Receptor 1B)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)HTR2B (5-Hydroxytryptamine Receptor 2B)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on 2C-B prodrug.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2C-B prodrug.